2,522
Views
5
CrossRef citations to date
0
Altmetric
Clinical Research

Clinical outcomes from early use of digoxin-specific antibodies versus observation in chronic digoxin poisoning (ATOM-4)

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, & ORCID Icon show all
Pages 638-643 | Received 07 Sep 2018, Accepted 05 Nov 2018, Published online: 26 Dec 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Betty S. Chan, Geoffrey K. Isbister, Angela Chiew, Katherine Isoardi & Nicholas A. Buckley. (2022) Clinical experience with titrating doses of digoxin antibodies in acute digoxin poisoning. (ATOM-6). Clinical Toxicology 60:4, pages 433-439.
Read now

Articles from other publishers (4)

Paul Andrews, Kurt Anseeuw, Dipak Kotecha, Frédéric Lapostolle & Ruben Thanacoody. (2023) Diagnosis and practical management of digoxin toxicity: a narrative review and consensus. European Journal of Emergency Medicine 30:6, pages 395-401.
Crossref
Marieke A. Dijkman, Femke M. J. Gresnigt & Dylan W. de Lange. (2023) Digoxin-specific antibodies: a novel dosing strategy. Netherlands Heart Journal.
Crossref
Stephanie Digiovanni-Kinsley, Brandon Duke, Richard Giovane & Cameron Paisley. (2021) A Case of Digoxin Toxicity Due to Acute Renal Failure. Cureus.
Crossref
Maude St-Onge. (2021) Cardiovascular Drug Toxicity. Critical Care Clinics 37:3, pages 563-576.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.